Lonza | LONN - Ebit

Aktienkurs
506.20
Täglich Wechseln
-2.40 -0.47%
Monatlich
1.95%
Jährlich
-2.95%
Q2 Prognose
499.29




Ebit Veränderung Datum
Akzo Nobel EUR 217M 80M 2025-12
Alcon AG USD 317M 17M 2025-12
Almirall EUR 30.23M 12.8M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
BASF EUR -175M 668M 2025-12
Bayer EUR 1.11B 1.51B 2025-12
Beiersdorf EUR 504M 312M 2025-12
Covestro EUR -324M 5.72B 2025-12
Demant DKK 2.07B 201M 2025-12
Fresenius EUR 713M 139M 2025-12
Fresenius Medical Care EUR 663M 213.06M 2025-12
Geberit CHF 134.1M 65.8M 2025-12
Genmab DKK 260M 199M 2025-12
Givaudan CHF 610M 149M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
GN Store Nord DKK 570M 230M 2025-12
Hikma Pharmaceutical USD 348M 31M 2025-12
Johnson Matthey GBP 142M 89M 2025-12
Merck EUR 474M 738M 2025-12
Novartis USD 4.06B 530M 2025-12
Philips EUR 719M 390M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Sika AG CHF 724.9M 73.2M 2025-12
Smith & Nephew USD 440M 50M 2025-12
Solvay EUR 60M 27M 2025-12
UCB EUR 1.29B 571M 2025-12